Turn Therapeutics Inc. (TTRX) Research

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Market snapshot

Symbol
TTRX
Price
$5.87
Day change
-2.65%
Market cap
$174.9M
P/E ratio
-45.10x
52-week range
2.57-26.5
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months

Peer companies

  • Agenus Inc. (AGEN)
  • Anixa Biosciences, Inc. (ANIX)
  • Cognition Therapeutics, Inc. (CGTX)
  • Greenwich LifeSciences, Inc. (GLSI)
  • TuHURA Biosciences, Inc. (HURA)
  • Inhibikase Therapeutics, Inc. (IKT)
  • Opus Genetics, Inc. (IRD)
  • Seer, Inc. (SEER)

Open Turn Therapeutics Inc. (TTRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.